TAVI Forum 13 Webinar

E-mail Print

On Thursday, October 30, 2025, the Forum for Collaborative Research convened its 13th TAVI Forum meeting as an online Zoom webinar

Materials

pdfAgenda
pdfParticipant List

Introductory Remarks

pdfWelcome and Introductions
Shilpa Mitra, Forum for Collaborative Research
Veronica Miller, Forum for Collaborative Research
Per Ljungman, Karolinska University Hospital
Camille Kotton, Massachusetts General Hospital

Session I: Industry Updates: BKV

Potravitug Safe-Kidney II Results
Jürgen Beck, Memo Therapeutics AG

pdfAIC468 Phase 1 Safety and Pharmacokinetic Data
Vedran Pavlovic, AiCuris Anti-Infective Cures AG

Direct-acting, Small-molecule Antivirals Designed for Prophylactic and Therapeutic Use Against BK and JC Polyomavirus Infections
Ali Munawar, Orthogon Therapeutics, LLC

Open Discussion
All Meeting Participants

Session II: Industry Updates: Adenovirus

Brincidofovir (BCV) for post-HCT Adenovirus Infection
Nkechi Azie, Symbio Pharmaceuticals Ltd.

Open Discussion
All Meeting Participants

Session III: Industry Updates: CMV

pdfKamada's US Clinical Program: Investigator-Initiated Studies with Cytogam
Winston Ally, Kamada Ltd

Interim Assessment of Safety and Immunogenicity from a Proof-of-Concept Phase 2 Trial of an mRNA-Based CMV Vaccine in Patients Who Have Undergone Allogeneic HCT
Jennifer Husson, Moderna, Inc.

pdfArtesunate for Injection® as Combination Therapy for Treatment of CMV in Transplant Recipients
Bryan Smith, Amivas, Inc.
Lisa Thomas Read, Amivas, Inc.

Open Discussion
All Meeting Participants

Session IV: New Topics in Transplant and Immunocompromised Populations

Systemic Immune Effects of Asymptomatic CMV (verses other herpesviruses) In Treated HIV 
Peter Hunt, Univ of California San Francisco

pdfHHV-8/Kaposi's Sarcoma-Associated Herpesvirus Infection in SOT: Unmet Needs
Alessandra Mularoni, ISMETT / University of Pittsburgh Medical Center

pdfTabelecleucel: Investigational Proposed Therapy for EBV+ Post-transplant Lymphoproliferative Disease (PTLD)
Ruchit Parikh, Pierre-Fabre Pharmaceuticals Inc.

Open Discussion
All Meeting Participants

Concluding Remarks

Next Steps
Veronica Miller, Forum for Collaborative Research
Per Ljungman, Karolinska University Hospital
Camille Kotton, Massachusetts General Hospital
Shilpa Mitra, Forum for Collaborative Research